2. North America Home Medical Devices Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restrictions
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. North America Home Medical Devices Market Analysis
10.1.Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2.Bargaining Power of Suppliers
10.1.3.Threat of Substitutes
10.1.4.Rivalry
10.2.PEST Analysis
10.2.1.Political
10.2.2.Economic
10.2.3.Social
10.2.4.Technological
11. North America Home Medical Devices Market
11.1.Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; YoY Growth (%) 2021-2030F
12. North America Home Medical Devices Market: Market Segmentation
12.1.By Regions
12.1.1.North America:(US and Canada), By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.1.2.Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.1.3.Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.1.4.Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.1.5.Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.2.By Functionality: Market Share (2020-2030F)
12.2.1. Therapeutic Equipment, By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.2.2. Home Respiratory Therapy Equipment, By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.2.3. Home IV Equipment, By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.2.4. Home Dialysis Equipment, By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.2.5. Others, By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.3.By End-user: Market Share (2020-2030F)
12.3.1. Hospitals and ASC's, By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.3.2. Clinics, By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
12.3.3. Others, By Value (USD Million) 2020-2030F; YoY Growth (%) 2021-2030F
13. Company Profile
14. 3M Co.
14.1. Company Overview
14.2. Company Total Revenue (Financials)
14.3. Market Potential
14.4. Global Presence
14.5. Key Performance Indicators
14.6. SWOT Analysis
14.7. Product Launch
15. Abbott Laboratories
16. Allergan Inc.
17. Baxter International Inc.
18. Bayer
19. Becton, Dickinson and Co.
20. Boston Scientific Corp.
21. Cardinal Health Inc.
22. Covidien plc
23. Cryolife Inc.
24. Danaher
25. Depuy Synthes
26. Endologix, Inc.
27. Essilor International SA
28. Other Prominent Players
29. Consultant Recommendation
The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Select License Type